Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00943527|
Recruitment Status : Completed
First Posted : July 22, 2009
Last Update Posted : January 25, 2012
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||110 participants|
|Official Title:||Molecular Breast Imaging: Effect of Menstrual Cycle, Hormone Therapy, and Tamoxifen on Tc-99m Sestamibi Uptake in the Breast.|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||January 2012|
Premenopausal Women who are not taking hormones or birth control. Ages 35-45 who have had a negative mammograph performed at the Mayo Clinic in Rochester within the last year.
Women Initiating Hormone Therapy and have had a negative mammogram preformed at the Mayo Clinic Rochester within the last year.
Women Initiating Tamoxifen who have had a negative mammogram preformed at the Mayo Clinic Rochester.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00943527
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|